Clinical Trial Update: A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of bortezomib conducted in Taiwanese patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Multiple Myeloma | Phase 4 | Status: COMPLETED